SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Dermatology

Volumn 44, Issue 5, 2001, Pages 807-813

Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial

(7) Marks, Robin a Gebauer, Kurt b Shumack, Stephen c Amies, Mark d Bryden, James d Fox, Terry L d Owens, Mary L d

a SKIN AND CANCER FOUNDATION (Australia)

b FREMANTLE HOSPITAL (Australia)

c ST GEORGE HOSPITAL (Australia)

d 3M COMPANY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; IMMUNOMODULATING AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EROSION; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN EDEMA; SKIN INFLAMMATION; SKIN ULCER;

EID: 0035028717 PISSN: 01909622 EISSN: None Source Type: Journal
DOI: 10.1067/mjd.2001.113689 Document Type: Article

Times cited : (308)

References (11)

1
- 0031708836
- Trends in the incidence of nonmelanocytic skin cancer (NMSC) treated in Australia 1985-1995: Are primary prevention programs starting to have an effect?
- (1998) Int J Cancer , vol.78 , pp. 144-148
- Staples, M.¹ Marks, R.² Giles, G.³

2
- 0030924338
- Differences in age and body site distribution of the histological subtypes of basal cell carcinoma: A possible indicator of differing causes
- (1997) Arch Dermatol , vol.133 , pp. 593-596
- McCormack, C.J.¹ Kelly, J.W.² Dorevitch, A.P.³

3
- 0026592264
- Guidelines for care of basal cell carcinoma
- (1992) J Am Acad Dermatol , vol.26 , pp. 117-120
- Drake, L.A.¹ Ceilley, R.I.² Cornelison, R.L.³ Dobes, W.A.⁴ Dorner, W.⁵ Goltz, R.W.⁶

4
- 0025083873
- Intralesional interferon therapy for basal cell carcinoma
- (1990) J Am Acad Dermatol , vol.23 , pp. 694-700
- Cornell, R.C.¹ Greenway, H.T.² Tucker, S.B.³ Edwards, L.⁴ Ashworth, S.⁵ Vance, J.C.⁶

5
- 85031517839
- National cancer control plan and implementation strategy: a report by the National Cancer Control Initiative to the Commonwealth Department of Health & Family Services. December 1997. Victoria: NCCI
- (1997) , pp. 6-7

6
- 0031937435
- Treatment of genital warts with an immune response modifier (imiquimod)
- (1998) J Am Acad Dermatol , vol.38 , pp. 230-239
- Beutner, K.R.¹ Spruance, S.L.² Hougham, A.J.³ Fox, T.L.⁴ Owens, M.L.⁵ Douglas J.M., Jr.⁶

7
- 0032694077
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
- (1999) J Am Acad Dermatol , vol.41 , pp. 1002-1007
- Beutner, K.R.¹ Geisse, J.R.² Helman, D.³ Fox, T.L.⁴ Ginkel, A.⁵ Owens, M.L.⁶

8
- 0027532008
- Trends in non-melanocytic skin cancer treated in Australia: The second national survey
- (1993) Int J Cancer , vol.53 , pp. 585-590
- Marks, R.¹ Staples, M.² Giles, G.G.³

9
- 0003379297
- Surgical management of local disease
- Miller SJ, Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis and management. Malden (MA): Blackwell Science
- (1997) , pp. 664-671
- Ratner, D.¹ Skouge, J.W.²

10
- 0005057657
- Cryosurgery
- Miller SJ, Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis and management. Malden (MA): Blackwell Science
- (1997) , pp. 672-675
- Kuflike, G.¹

11
- 4243295169
- Biologic response modifiers
- Miller SJ, Maloney ME, editors. Cutaneous oncology: pathophysiology, diagnosis and management. Malden (MA): Blackwell Science
- (1997) , pp. 681-686
- Greenway, H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.